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Statement of findings
IL-10, IL-13, IFN-g, tumor necrosis factor (TNF)-a, LT-a, CD154, and TNF-related activation-
induced cytokine (TRANCE) were expressed by 2–20% of rheumatoid arthritis (RA) synovial
tissue CD4+ memory T cells, whereas CD4+ cells that produced IL-2, IL-4, or IL-6 were not
detected. Expression of none of these molecules by individual CD4+ cells correlated with
the exception of TRANCE and IL-10, and TRANCE and TNF-a. A correlation between
expression of IL-10 and CCR7, LT-a and CCR6, IFN-g and CCR5, and TRANCE and
CXCR4 was also detected.
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Introduction: In RA large numbers of CD4+ memory T cells
infiltrate the inflamed synovium [1–3]. The accumulated CD4+
memory T cells in the RA synovium appear to be activated,
because they express cytokines and activation markers [4–8].
Expressed cytokines and activation markers should play important
roles in the pathogenesis of RA. However, the frequency of
cytokine expression by RA synovial CD4+ T cells has not been
analyzed accurately. Recently, the roles of chemokine and
chemokine receptor interactions in T-cell migration have been
intensively examined. Interactions of chemokine and chemokine
receptors might therefore be important in the accumulation of the
CD4+ T cells in the RA synovium. Accordingly, correlation of
cytokine and chemokine receptor expression might be important
in delineating the function and potential means of accumulation of
individual CD4+ memory T cells in the RA synovium.
In the present study we analyzed cytokine (IL-2, IL-4, IL-6,
IL-10, IL-13, IFN-g, TNF-a, and LT-a), activation marker
(CD154 [CD40 ligand] and TRANCE – also called receptor
activator of nuclear factor kB ligand [RANKL] or osteoclast
differentiation factor [ODF]), and chemokine receptor
expression by individual CD4+ memory T cells isolated from
rheumatoid synovium and blood. To achieve this we employed
a single-cell reverse transcription (RT) polymerase chain
reaction (PCR) technique. This technique made it possible to
correlate mRNAs expressed by individual CD4+ memory T cells
in the synovium and blood.
Materials and method: Synovial tissues from three RA
patients and peripheral blood mononuclear cells from two RA
patients and a normal donor were analyzed.
Cytokine (IL-2, IL-4, IL-6, IL-10, IL-13, IFN-g, TNF-a, and LT-a)
and activation marker (CD154 and TRANCE) expression by
individual CD4+CD45RO+ T cells from RA synovium or blood
were analyzed using a single-cell RT-PCR. In brief, single
CD4+CD45RO+ T cells was sorted into each well of a 96-well
PCR plate using a flow cytometer. cDNA from individual cells
was prepared, and then the cDNA was nonspecifically amplified.
The product was then amplified by PCR using gene-specific
primers to analyze cytokine and activation marker expression.
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Results: Cytokine and activation marker expression by individual
CD4+CD45RO+ T cells from RA synovial tissues was analyzed
using a single-cell RT-PCR method. Expression of mRNAs was
analyzed in 152 individual synovial tissue CD4+CD45RO+
T cells sorted from three RA patients in which T-cell receptor
(TCR) Cb mRNA was detected. Frequencies of CD4+ memory
T cells expressing cytokine and activation marker mRNA in RA
synovium are shown in Table 1. IL-2, IL-4, and IL-6 were not
expressed by the synovial tissue CD4+CD45RO+ T cells,
whereas 2–20% of cells expressed the other cytokine mRNAs.
Few correlations between cytokine and activation marker
mRNAs were observed. Notably, no cells contained both IFN-g
and LT-a mRNAs, cytokines that are thought to define the T-
helper (Th)1 phenotype [9]. However, the frequency of
TRANCE-positive cells in IL-10-positive cells was significantly
higher than that in IL-10-negative cells (Table 2). Moreover, the
frequency of TRANCE-positive cells in TNF-a-positive cells
was also significantly higher than that in TNF-a-negative cells.
Varying percentages of CD4+ memory T cells expressed CC
and CXC chemokine receptors. The frequency of CCR5-
positive cells in IFN-g-positive cells was significantly higher than
that in IFN-g-negative cells, whereas the frequency of CCR6-
positive cells in LT-a-positive cells was significantly higher than
that in LT-a-negative cells, and the frequency of CCR7-positive
cells in IL-10-positive cells was significantly higher than that in
IL-10-negative cells. Furthermore, the frequency of CXCR4-
positive cells in TRANCE-positive cells was significantly higher
than that in TRANCE-negative cells.
Expression of cytokine and activation marker mRNAs was also
analyzed in 48 individual peripheral blood CD4+CD45RO+ T
cells from two RA patients. IL-2, IL-4, IL-6, and LT-a were not
expressed by the peripheral CD4+CD45RO+ T cells, whereas
4–17% of cells expressed the other markers. The most striking
difference between synovial tissue and peripheral blood CD4+
memory T cells was the presence of LT-a expression in the
former, but not in the latter. IFN-g and TNF-a were not expressed
by normal peripheral blood CD4+ memory T cells, although they
were expressed by RA peripheral blood CD4+ memory T cells.
Discussion: The present study employed a single-cell PCR
technology to analyze cytokine expression by unstimulated RA
synovial tissue CD4+ memory T cells immediately after
isolation, without in vitro manipulation. The results confirm the
Table 1
Frequencies of cytokine and activation marker expression by CD4+DC45RO+ T cells in synovial tissue of RA patients
IL-2 IL-4 IL-6 IL-10 IL-13 IFN-g TNF-a LT-a CD154 TRANCE
RA1 (n = 50) 0 (0) 0 (0) 0 (0) 7 (14) 0 (0) 11 (22) 0 (0) 6 (12) 7 (14) 8 (16)
RA2 (n = 39) 0 (0) 0 (0) 0 (0) 5 (13) 1 (3) 3 (8) 0 (0) 1 (3) 10 (26) 1 (3)
RA3 (n = 63) 0 (0) 0 (0) 0 (0) 4 (6) 4 (6) 4 (6) 3 (5) 4 (6) 14 (22) 3 (5)
Total (n = 152) 0 (0) 0 (0) 0 (0) 16 (11) 5 (3) 18 (12) 3 (2) 11 (7) 31 (20) 12 (8)
Values are expressed as number (percentage) of cytokine-positive cells in TCR Cb-positive cells.
Table 2
Correlation of cytokine expression in 152 individual RA synovial tissue CD4+ memory T cells
IL-13 IFN-g TNF-a LT-a CD154 TRANCE Total
IL-10 (+) 0 (0) 2 (13) 0 (0) 2 (13) 4 (25) 4 (25)* 16
IL-10 (–) 5 (4) 16 (12) 3 (2) 9 (7) 27 (20) 8 (6) 136
IL-13 (+) 1 (20) 1 (20) 0 (0) 0 (0) 1 (20) 5
IL-13 (–) 17 (12) 2 (1) 11 (7) 31 (21) 11 (7) 147
IFN-g (+) 0 (0) 0 (0) 4 (22) 3 (17) 18
IFN-g (–) 3 (2) 11 (8) 27 (20) 9 (7) 134
TNF-a (+) 0 (0) 0 (0) 2 (67)* 3
TNF-a (–) 11 (7) 31 (21) 10 (7) 149
LT-a (+) 4 (36) 1 (9) 11
LT-a (–) 27 (19) 11 (8) 141
CD154 (+) 1 (3) 31
CD154 (–) 11 (9) 121
Values are expressed as number (percentage) of cytokine-positive cells. *P < 0.05.http://arthritis-research.com/content/2/5/415
Introduction
In RA large numbers of CD4+ memory T cells infiltrate the
inflamed synovium [1–3]. The accumulated CD4+
memory T cells in the RA synovium appear to be acti-
vated, because they express cytokines and activation
markers [4–8]. Expressed cytokines and activation
markers should play important roles in the pathogenesis
of RA. However, the frequency of cytokine expression by
RA synovial CD4+ T cells has not been analyzed accu-
rately. Recently, the roles of chemokine and chemokine
receptor interactions in T-cell migration have been inten-
sively examined. Interactions of chemokine and
chemokine receptors might therefore be important for the
accumulation of the T cells in the RA synovium. Accord-
ingly, correlation of cytokine and chemokine receptor
expression might be important in delineating the function
and potential means of accumulation of individual CD4+
memory T cells in the RA synovium.
Full article
Th1 nature of rheumatoid inflammation. It is noteworthy that no
individual synovial CD4+ memory T cells expressed both IFN-g
and LT-a mRNAs, even though these are the prototypic Th1
cytokines [9]. These results imply that, in the synovium,
regulation of IFN-g and LT-a must vary in individual cells, even
though both Th1 cytokines can be produced.
The present data showed that CCR5 expression correlated
with IFN-g but not with LT-a expression by synovial CD4+
memory T cells. It has been reported that CCR5 expression is
upregulated in RA synovial fluid and synovial tissue T cells
[10–12] and that CCR5 D32 deletion may have an influence
on clinical manifestations of RA [13], suggesting that CCR5
might play an important role in RA. Recently, it has been
claimed that CCR5 was preferentially expressed by Th1 cell
lines [14,15]. However, in the present study CCR5 was not
expressed by all IFN-g-expressing cells. Moreover, CCR5
expression did not correlate with expression of LT-a by RA
synovial CD4+ memory T cells. Therefore, it is unclear whether
CCR5 is a marker of Th1 cells in RA synovium.
IL-10 expression correlated with CCR7 expression by RA
synovial CD4+ memory T cells. Recently, it was reported [16]
that in the blood CCR7+ CD4+ memory T cells express lymph-
node homing receptors and lack immediate effector function,
but efficiently stimulate dendritic cells. These cells may play a
unique role in the synovium as opposed to in the blood. By
producing IL-10, they might have an immunoregulatory
function. In addition, IL-10 expression also correlated with
expression of TRANCE. Although it is possible that IL-10
produced by these cells inhibited T-cell activation in the
synovium, TRANCE expressed by these same cells might
function to activate dendritic cells and indirectly stimulate T
cells, mediating inflammation in the synovium. These results
imply that individual T cells in the synovium might have
different, and sometimes opposite functional activities.
LT-a expression correlated with CCR6 expression by synovial
CD4+ memory T cells. It has been reported that CCR6 is
expressed by resting peripheral memory T cells [17], whereas
LT-a expression is associated with the presence of lymphocytic
aggregates in synovial tissue [7]. The correlation between the
expression of these two markers therefore suggests the
possibility that CCR6 may play a role in the development of
aggregates of CD4+ T cells that are characteristically found in
rheumatoid synovium.
TRANCE is known to be expressed by activated T cells, and
can stimulate dendritic cells and osteoclasts [18]. Of note,
TRANCE-mediated activation of osteoclasts has recently been
shown [19] to play an important role in the damage to bone
that is found in experimental models of inflammatory arthritis. It
is therefore of interest that TRANCE was expressed by 3–16%
of the RA synovial CD4+ memory T cells. Of note, 67% of TNF-
a-positive cells expressed TRANCE. In concert, TNF-a and
TRANCE expressed by this subset of CD4+ memory T cells
might make them particularly important in mediating the bony
erosions that are characteristic of RA.
Interestingly, there was a correlation between expression of IFN-
g and IL-10 in RA peripheral blood CD4+ memory T cells. In RA
peripheral blood, CD154 expression correlated with that of
CXCR3 by CD4+ memory T cells. It has been claimed [15] that
CXCR3 is preferentially expressed by in vitro generated Th1
cells. However, in the present study CXCR3 did not correlate
with IFN-g expression. Although IFN-g and TNF-a mRNAs were
expressed in vivo by peripheral blood CD4+ T cells from RA
patients, LT-a mRNA was not detected, whereas IFN-g, TNF-a,
and LT-a were not detected in samples from healthy donors.
These findings indicate that RA peripheral blood CD4+ memory
T cells are stimulated in vivo, although they do not express LT-a
mRNA. The present studies indicate that the frequencies of
CD4+ memory T cells that expressed IFN-g in the blood and in
the synovium are comparable. These results imply that activated
CD4+ memory T cells migrate between blood and synovium,
although the direction of the trafficking is unknown. The
presence of LT-a mRNA in synovium, but not in blood, indicates
that CD4+ memory cells are further activated in the synovium,
and that these activated CD4+ memory T cells are retained in
the synovium until LT-a mRNA decreases.
In conclusion, CD4+ memory T cells are biased toward Th1
cells in RA synovium and peripheral blood. In the synovium,
IFN-g and LT-a were produced by individual cells, whereas in
the rheumatoid blood no LT-a-producing cells were detected.
Furthermore, there were modest correlations between
individual cells that expressed particular cytokines, such as IL-
10, and certain chemokine receptor mRNAs.In order to analyze cytokine, activation marker, and chemo-
kine receptor expression by individual CD4+ memory T
cells, we used a single-cell RT-PCR technique. The
method made it possible to analyze cytokine and
chemokine receptor expression by individual RA synovial
CD4+ memory T cells without in vitro stimulation, and to
correlate cytokine and chemokine receptor expression.
Using this technique, we analyzed cytokine (IL-2, IL-4,
IL-6, IL-10, IL-13, IFN-g, TNF-a, and LT-a), activation
marker (CD154 [CD40 ligand] and TRANCE – also called
receptor activator of nuclear factor-kB ligand [RANKL] or
osteoclast differentiation factor [ODF]), and chemokine
receptor expression by individual CD4+ memory T cells
isolated from rheumatoid synovium and blood. The results
indicate that CD4+ memory T cells are biased toward Th1
cells in RA synovium, although individual cells produced
IFN-g or LT-a, but not both. A similar pattern of cytokine
production was observed with CD4+ memory T cells from
RA blood, with the exception that no cells expressing LT-a
were detected. There were modest correlations between
individual cells that expressed particular cytokine and
chemokine receptor mRNAs.
Materials and method
Specimens
Synovial tissues were obtained at surgery from three RA
patients. The synovial tissue was minced and incubated
with 0.3 mg/ml collagenase (Sigma, St Louis, MO, USA) for
1 h at 37°C in RPMI 1640 medium (Life Technologies,
Gaithersburg, MD, USA). Partially digested pieces of the
tissue were pressed through a metal screen to obtain
single-cell suspensions. Mononuclear cells were then iso-
lated by ficoll-hypaque (Pharmacia Biotech, Piscataway, NJ,
USA) gradient centrifugation. RA was diagnosed according
to the American College of Rheumatology criteria [20].
Also, peripheral blood mononuclear cells were separated
by ficoll-hypaque gradient centrifugation from two RA
patients and a normal donor.
Single cell sorting and reverse transcription polymerase
chain reaction
The method for construction of cDNA libraries from single
cells was similar to previously reported techniques
[21,22]. RA synovial tissue T cells were analyzed without
in vitro culture or stimulation by staining synovium
mononuclear cells with FITC-conjugated anti-CD4 mono-
clonal antibody (Q4120; Sigma) and PE-conjugated anti-
CD45RO monoclonal antibody (UCHL-1), after which
individual CD4+CD45RO+ T cells were sorted in a 96-well
PCR plate (Robbins Scientific, Sunnyvale, CA, USA)
using the FACStarPlus (Becton Dickinson, San Jose, CA,
USA). Peripheral CD4+CD45RO+ single cells were also
sorted into wells of 96-well PCR plates using the FAC-
StarPlus flow cytometer.
Each well contained 4 ml lysis buffer (50 mmol/l Tris-HCl
[pH 8.3], 75 mmol/l KCl, 3 mmol/l MgCl2, 1 mmol/l DTT,
10 mmol/l dNTP [Sigma], 5 U/ml PRIME RNase Inhibitor [5
Prime  ® 3 Prime Incorporated, Boulder, CO, USA],
300 U/ml RNAguard [Pharmacia Biotech], 200 ng/ml
oligo[dT]24 [Integrated DNA Technologies Incorporated,
Coralville, IA, USA], and 0.5% NP-40). The samples were
heated to 65°C for 1 min, cooled to 20°C for 3 min, and
maintained on ice. Two units of AMV Reverse Transcrip-
tase (Promega, Madison, WI, USA) and 50 U of M-MLV
Reverse Transcriptase (Life Technologies) was added, and
the samples were incubated at 37°C for 15 min before
heat inactivation at 65°C for 10 min. For polyadenylate
tailing at the 3¢ end of the cDNA, 5 ml tailing buffer
(200 mmol/l potassium cacodylate [pH 7.2], 4 mmol/l
CoCl2, 0.4 mmol/l DTT), 2 mmol/l dATP (Roche, Indianapo-
lis, IN, USA), and 10 U terminal transferase (Roche) were
added, and incubated at 37°C for 20 min, followed by heat
inactivation at 65°C for 10 min. To amplify the cDNA non-
specifically, PCR was performed with 100 ml of 10 mmol/l
Tris-HCl (pH 9.0), 50 mmol/l KCl, 2.5 mmol/l MgCl2,
0.01% Triton-X, 1 mmol/l dNTP, 10 U Taq DNA poly-
merase (Promega), and 2 mmol/l X-(dT)24 primer (ATG
TCG TCC AGG CCG CTC TGG ACA AAA TAT GAA
TTC-dT24; Integrated DNA Technologies Incorporated).
Twenty-five cycles of amplification were performed with
1 min at 94°C, 2 min at 42°C, and 6 min at 72°C, plus 10 s
extension per cycle. Afterward, 5 U Taq DNA polymerase
was added, followed by an additional 25 cycles of PCR.
For gene-specific amplification, 1 ml of nonspecifically
amplified cDNA was amplified by PCR in 25 ml 10 mmol/l
Tris-HCl (pH 9.0), 50 mmol/l KCl, 1.5 mmol/l MgCl2,
0.01% Triton-X, 200 mmol/l dNTP and 0.625 U Taq DNA
polymerase. The cycling program was: 94°C for 1 min,
60°C for 1 min (58°C: IL-2, IL-4, IFN-g), and 72°C for
1 min for 35 cycles, followed by a final extension for 7 min.
For nested amplification, 1 ml of amplified PCR reaction
mixture was added to a second PCR reaction mixture
(50 ml of 10 mmol/l Tris-HCl [pH 9.0], 50 mmol/l KCl,
1.5 mmol/l MgCl2, 0.01% Triton-X, 200 mmol/l dNTP, and
1.25 U Taq DNA polymerase). The cycling program was:
94°C for 1 min, 60°C for 1 min, and 72°C for 1 min for 35
cycles, followed by a final extension for 7 min. The PCR
products were then separated by electrophoresis through
2.0% agarose. The primers were designed to be within
600 bp of the 3¢ end of each mRNA. The primers used
were as shown in Table 3.
To confirm that the PCR products were amplified from the
corresponding genes, the nucleotide sequences of the
PCR products were analyzed. More than five PCR prod-
ucts of each cytokine from a total of two or three donors
were sequenced. All the sequences of the PCR products
were identical to the previously published sequences
(data not shown).
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sorting, TCR Vb mRNA was analyzed by single-cell RT-
PCR using Vb family-specific primers. In the wells ana-
lyzed, only one TCR Vb was detected (data not shown).
Statistical analyses
To analyze correlations between cytokines and chemokine
receptor expressions, and to compare frequencies of
chemokine receptor-expressing cells between different T-
cell subsets, Fisher’s exact probability test was used.
Results
Cytokine and activation marker expression by individual
rheumatoid synovial tissue CD4+ memory T cells
Cytokine and activation marker expressions by individual
CD4+CD45RO+ T cells from RA synovial tissues were
analyzed by employing a single-cell RT-PCR method.
Expressions of mRNAs were analyzed in 152 individual
synovial tissue CD4+CD45RO+ T cells sorted from three
RA patients in which TCR Cb mRNA was detected.
Cytokine and activation marker expressions by 50 synovial
tissue CD4+CD45RO+ T cells (RA1) are shown in Fig. 1.
Frequencies of CD4+ memory T cells that expressed
cytokine and activation marker mRNA in RA synovium are
shown in Table 1. IL-2, IL-4, and IL-6 were not expressed
by the synovial tissue CD4+CD45RO+ T cells, whereas
2–20% of cells expressed the other mRNAs.
Correlation of the expression of cytokines by rheumatoid
synovial tissue CD4+ memory T cells
Few correlations between cytokine and activation marker
mRNAs were observed. Notably, no cells contained
mRNAs for both IFN-g and LT-a, cytokines that are
thought to define the Th1 phenotype [9]. However, the fre-
quency of TRANCE-positive cells in IL-10-positive cells
was significantly higher than that in IL-10-negative cells
(Table 2). Moreover, the frequency of TRANCE-positive
cells in TNF-a-positive cells was also significantly higher
than that in TNF-a-negative cells.
Correlation of cytokine and chemokine receptor expression
by RA synovial tissue CD4+ memory T cells
Varying percentages of CD4+ memory T cells expressed
CC and CXC chemokine receptors as shown in Tables 4
and 5. Thus, for example, 21% of RA synovial CD4+
memory T cells expressed CCR5, 39% CCRb, and 19%
CCR7 mRNAs, whereas 16% expressed CXCR3 and
76% expressed CXCR4 mRNAs. The frequency of
CCR5-positive cells in IFN-g-positive cells was signifi-
cantly higher than that in IFN-g-negative cells (Table 4),
whereas the frequency of CCR6-positive cells in LT-a-
positive cells was significantly higher than that in LT-a-
negative cells, and the frequency of CCR7-positive cells in
IL-10-positive cells was significantly higher than that in
IL-10-negative cells. Furthermore, the frequency of
http://arthritis-research.com/content/2/5/415
Table 3
Primers used for PCR amplification
Cytokine/chemokine receptor Primer
IL-2 5¢-TAC AAG AAT CCC AAA CTC ACC AGG A
3¢-GTC AGT GTT GAG ATG ATG CTT TGA CA
3¢ (nested)-TGG TTG CTG TCT CAT CAG CAT ATT CA
IL-4 5¢-CTT TGC TGC CTC CAA GAA CAC AAC T
3¢-TCT CAT GAT CGT CTT TAG CCT TTC CA
3¢ (nested)-TCC TTC ACA GGA CAG GAA TTC AAG C
IL-6 5¢-GTT CCT GCA GAA AAA GGC AAA G
3¢-CTG AGG TGC CCA TGC TAC ATT T
5¢ (nested)-CTA GAT GCA ATA ACC ACC CCT GA
IL-10 5¢-TTA GGA AGA GAA ACC AGG GAG CC
3¢-GCT GGC CAC AGC TTT CAA GAA T
5¢ (nested)-CAG GGA GCC CCT TTG ATG ATT A
IL-13 5¢-ACC CAG GGA TGA CAT GTC CCT A
3¢-CCC AAC GGT GAC AAA CAC ACT C
3¢ (nested)-AAG AAG TGT GCC TGA GCT GCT GT
IFN-g 5¢-AAG GCT TTA TCT CAG GGG CCA ACT
3¢-TGG AAG CAC CAG GCA TGA AAT CTC
5¢ (nested)-CAA GAT CCC ATG GGT TGT GTG TTT
TNF-a 5¢-GGC TCA GAC ATG TTT TCC GTG A
3¢-CTC AGC AAT GAG TGA CAG TTG G
5¢ (nested)-CAA TAG GCT GTT CCC ATG TAG CC
LT-a 5¢-CCT GAA CCA TCC CTG ATG TCT G
3¢-AAA TAG TCC CCT CCC TGC CTC T
3¢ (nested)-TCT AGT CAT CCC CCA AGC TCC TC
CD154 5¢-AGT CAG GCC GTT GCT AGT CAG T
3¢-GGA AAC AAT GGA GAC TGC AGG TA
3¢ (nested)-TAA TGA GGA GTG GGC AGG CTC AG
TRANCE 5¢-GAA AAC TTG CAG CTA AGG AGG GG
3¢-GGT GGC CAA CAT CCT GCT TAT T
3¢ (nested)-CCT GCT TAT TAT TCA AGG CAT CC
CCR1 5¢-GAT TTG GGC TCT TGG AAT CCT G
3¢-GTG CTT AGC CCA CTC CCT GAA T
3¢ (nested)-AGG GCT TTC TTA GTT CCA CTG CC
CCR2 5¢-TGG GAG TTT TGG TGG AGT CCG AT
3¢-GGG GGA TGT GGC CTA AGA AGC AT
3¢ (nested)-GCC TAA GAA GCA TCT GAA CAA TGG
CCR3 5¢-CTA AGG TCA TTA CCA CAG GCC AGG
3¢-AGC AGG GAA AGA ACT AGG CAC ATT
5¢ (nested)-GCA GCG TAC TCA TCA TCA ACC C
CCR5 5¢-CTC AGG GAA TGA AGG TGT CAG A
3¢-TGC TAC TGT TGC ACT CTC CAC AAC T
5¢ (nested)-AGC CTC TGA ATA TGA ACG GTG AGC
CCR6 5¢-CAT GGA ACT CAT GTT TTT AAA GGG C
3¢-CCA TGC CTA GCC CAT GAC AGT A
3¢ (nested)-CCC ATG ACA GTA CCT TCC TAA CA
CCR7 5¢-AGC ACA CTC ATC CCC TCA CTT G
3¢-AGC CAA GAG CTG AGT GCA TGT C
3¢ (nested)-GAG TGC ATG TCA TCC CCA CTC T
CXCR1 5¢-CAG ATC TAT GCC ACA AGA ACC CC
3¢-CTT TCT AGG GAT GCT GAT GCT GC
3¢ (nested)-CTG ATG CTG CAC GCC AGC CTG GA
CXCR2 5¢-ATT ACC AGG GAC TGA GGG GAG GG
3¢-GTG GCA TTA AGT CAC ATT GCG G
3¢ (nested)-GTC ACA TTG CGG TAC AAC TAT CAC
CXCR3 5¢-CAC TGC CCT TCT CAT TTG GAA ACT
3¢-GCA AAT ATA GAG GTC TTG GGG AC
5¢ (nested)-AGT ACA AGG CAT GGC GTA GAG GG
CXCR4 5¢-GGA CCT GTG GCC AAG TTC TTA GTT
3¢-ACT GTA GGT GCT GAA ATC AAC CCA
3¢ (nested)-CAG CTG GGG ATC ATT TCT AGC TTT
CXCR5 5¢-CAG GAC AAC GAG AAA GCC CTA AG
3¢-GGT CTC TGT GCT GCC TGT ACT GT
5¢ (nested)-GTA TCT CCT CGC AAG CTG GGT AA
TCR Cb 5¢-TCA AGT CCA GTT CTA CGG GCT C
3¢-TCA TAG AGG ATG GTG GCA GAC A
5¢ (nested)-CTC TCG GAG AAT GAC GAG TGG ACCXCR4-positive cells in TRANCE-positive cells was sig-
nificantly higher than that in TRANCE-negative cells
(Table 5).
Cytokine and activation marker expression by peripheral
blood CD4+ memory T cells from RA patients and a normal
donor
Expressions of cytokine and activation marker mRNAs was
also analyzed in 48 individual peripheral blood
CD4+CD45RO+ T cells sorted from two RA patients and in
33 individual peripheral blood CD4+CD45RO+ T cells
sorted from a normal donor. Frequencies of CD4+ memory
T cells that expressed cytokine and activation marker
mRNA are shown in Table 6. IL-2, IL-4, IL-6, and LT-a were
not expressed by the RA peripheral blood CD4+CD45RO+
T cells, whereas 4–17% of cells expressed the other
markers. The most striking difference between RA synovial
tissue and peripheral blood CD4+ memory T cells was the
presence of LT-a expression in the former, but not in the
latter. IFN-g and TNF-a were not expressed by normal
peripheral blood CD4+ memory T cells, although they were
expressed by RA peripheral blood CD4+ memory T cells.
Variable frequencies of RA peripheral CD4+ memory
T cells expressed chemokine receptor mRNAs. Except for
significantly decreased expressions of CCR5 and
CXCR4, there were no differences between chemokine
receptor expressions by synovial tissue and peripheral
blood CD4+ memory T cells. In peripheral blood CD4+
memory T cells, there was a significant correlation
between IFN-g and IL-10 expressions, and IFN-g and
CCR6 expressions (P < 0.05; Table 7). In addition,
CD154 and CXCR3 expressions correlated (P < 0.005).
No other correlations were detected (data not shown).
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Figure 1
Cytokine and activation marker expressions by CD4+CD45RO+ T cells
from RA synovial tissue (RA1). RA synovial tissue CD4+CD45RO+
T cells were sorted, and cytokine and activation marker expressions
were immediately determined in the TCR Cb (TCRBC) mRNA-positive
wells employing single-cell RT-PCR. Amplified PCR products were
separated by electrophoresis through 2.0% agarose. As negative
controls, one well that did not contain a cell (C1) and one well that
was not prepared with reverse transcriptase (C2) were analyzed.
Table 4
Correlation of cytokine and CC chemokine receptor expression in 152 individual RA synovial tissue CD4+ memory T cells
CCR1 CCR2 CCR3 CCR5 CCR6 CCR7 Total
IL-10 (+) 2 (13) 1 (6) 2 (13) 4 (25) 8 (50) 7 (44)* 16
IL-10 (–) 15 (11) 7 (5) 5 (4) 28 (21) 51 (38) 22 (16) 136
IL-13 (+) 0 (0) 0 (0) 0 (0) 1 (20) 3 (60) 2 (40) 5
IL-13 (–) 17 (12) 8 (5) 7 (5) 31 (21) 56 (38) 27 (18) 147
IFN-g (+) 0 (0) 3 (17) 1 (6) 8 (44)* 9 (50) 4 (22) 18
IFN-g (–) 17 (13) 5 (4) 6 (4) 24 (18) 50 (37) 25 (19) 134
TNF-a (+) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3
TNF-a (–) 17 (11) 8 (5) 7 (5) 32 (21) 59 (40) 29 (19) 149
LT-a (+) 0 (0) 1 (9) 0 (0) 1 (9) 8 (73)* 4 (36) 11
LT-a (–) 17 (12) 7 (5) 7 (5) 31 (22) 51 (46) 25 (18) 141
CD154 (+) 3 (10) 4 (13) 1 (3) 6 (19) 14 (45) 9 (29) 31
CD154 (–) 14 (12) 4 (4) 6 (5) 26 (21) 45 (37) 20 (17) 121
TRANCE (+) 1 (8) 1 (8) 2 (17) 3 (25) 6 (50) 4 (33) 12
TRANCE (–) 16 (11) 7 (5) 5 (4) 29 (21) 53 (38) 25 (18) 140
Values are expressed as number (percentage) of cytokine-positive cells. *P < 0.05.Discussion
The present study employed single-cell PCR technology
to analyze cytokine mRNA expressions by unstimulated
RA synovial tissue CD4+ memory T cells immediately after
isolation, without in vitro manipulation. The results are con-
sistent with the Th1 nature of rheumatoid inflammation.
These data showed that 6–22% of RA synovial CD4+
memory T cells produced IFN-g mRNA. Previous studies
[4–6] reported that 1–10% of RA synovial T cells
expressed IFN-g protein by immunohistologic analysis.
Although there is some variation in the results obtained
with the different methodologies, both results are consis-
tent with the conclusion that there is a Th1 bias in RA
[3,23]. It is noteworthy that no individual synovial CD4+
memory T cells expressed both IFN-g and LT-a mRNA,
http://arthritis-research.com/content/2/5/415
Table 5
Correlation of cytokine and CXC chemokine receptor expression in 152 individual RA synovial tissue CD4+ memory T cells
CXCR1 CXCR2 CXCR3 CXCR4 CXCR5 Total
IL-10 (+) 1 (7) 1 (7) 2 (13) 13 (81) 2 (13) 16
IL-10 (–) 9 (7) 12 (9) 23 (17) 103 (76) 14 (10) 136
IL-13 (+) 0 (0) 0 (0) 1 (20) 5 (100) 0 (0) 5
IL-13 (–) 10 (7) 13 (9) 24 (16) 111 (76) 16 (11) 147
IFN-g (+) 3 (17) 2 (11) 4 (22) 15 (83) 2 (11) 18
IFN-g (–) 7 (5) 11 (8) 21 (16) 101 (75) 14 (10) 134
TNF-a (+) 0 (0) 0 (0) 0 (0) 3 (100) 0 (0) 3
TNF-a (–) 10 (7) 13 (9) 25 (17) 113 (76) 16 (11) 149
LT-a (+) 1 (9) 0 (0) 2 (18) 10 (91) 2 (18) 11
LT-a (–) 9 (6) 13 (9) 23 (16) 106 (75) 14 (10) 141
CD154 (+) 3 (10) 2 (6) 5 (16) 27 (87) 6 (19) 31
CD154 (–) 7 (6) 11 (9) 20 (17) 89 (74) 10 (8) 121
TRANCE (+) 1 (8) 1 (8) 2 (17) 12 (100)* 2 (17) 12
TRANCE (–) 9 (6) 12 (9) 23 (16) 104 (74) 14 (10) 140
Values are expressed as number (percentage) of cytokine-positive cells. *P < 0.05.
Table 6
Frequencies of cytokine and activation marker expression by CD4+CD45RO+ T cells in peripheral blood of RA patients and a
normal donor
IL-2 IL-4 IL-6 IL-10 IL-13 IFN-g TNF-a LT-a CD154 TRANCE
RA
RA3 (n = 24) 0 (0) 0 (0) 0 (0) 3 (13) 0 (0) 3 (13) 2 (8) 0 (0) 4 (17) 3 (13)
RA4 (n = 24) 0 (0) 0 (0) 0 (0) 3 (13) 2 (8) 2 (8) 2 (8) 0 (0) 4 (17) 2 (8)
Total (n = 48) 0 (0) 0 (0) 0 (0) 6 (13) 2 (4) 5 (10) 4 (8) 0 (0) 8 (17) 5 (10)
Normal donor
Donor 1 (n = 33) 0 (0) 0 (0) 0 (0) 5 (15) 1 (3) 0 (0) 0 (0) 0 (0) 2 (6) 2 (6)
Values are expressed as number (percentage) of cytokine-positive cells in TCR Cb-positive cells.
Table 7
Correlation of cytokine and chemokine receptor expression in
individual CD4+ memory T cells of RA peripheral blood
IFN-g CD154
IL-10 (+) 3/3 (100)*
IL-10 (–) 2/45 (4)
CCR6 (+) 4/13 (31)*
CCR6 (–) 1/35 (3)
CXCR3 (+) 4/6 (67)†
CXCR3 (–) 4/42 (10)
Values are expressed as IFN-g or CD154 positive cells/cytokine or
chemokine receptor positive or negative cells (percentage). *P < 0.05,
†P < 0.005.even though these are the prototypic Th1 cytokines [9].
These results imply that, in the synovium, regulation of
IFN-g and LT-a must vary in individual cells, even though
both Th1 cytokine mRNAs can be expressed.
The present data showed that CCR5 expression corre-
lated with IFN-g but not with LT-a expression by synovial
CD4+ memory T cells. It has been reported that CCR5
expression is upregulated in RA synovial fluid and synovial
tissue T cells [10–12], and that CCR5 D32 deletion may
have an influence on clinical manifestations of RA [13],
suggesting that CCR5 might play an important role in RA.
Recently, it has been claimed [14,15] that CCR5 was
preferentially expressed by Th1 cell lines. In the present
study, however, CCR5 was not expressed by all IFN-g-
expressing cells. Moreover, CCR5 expression did not cor-
relate with expression of LT-a by RA synovial CD4+
memory T cells, although it correlated with IFN-g. There-
fore, it is unclear whether CCR5 is a marker of Th1 cells in
RA synovium.
Of RA synovial CD4+ T cells 6–14% expressed IL-10, and
the expression correlated with CCR7 expression. It has
been reported that approximately 1.5% of synovial T cells
express IL-10 by immunohistochemistry [5], and that 4%
of synovial CD4+ T cells have the potential to express IL-
10 [3]. Recently, it was reported [16] that, in the blood,
CCR7+CD4+ memory T cells express lymph-node homing
receptors and lack immediate effector function, but effi-
ciently stimulate dendritic cells. However, because 19% of
RA tissue CD4+ memory T cells expressed CCR7 and
there was a correlation between IL-10 production and
CCR7 expression, these cells may play a unique role in
the synovium as opposed to in the blood. By producing
IL-10, they may exert an immunoregulatory function. In
addition, it is interesting to note that IL-10 expression also
correlated with expression of TRANCE. Although it is pos-
sible that IL-10 produced by these cells inhibited T-cell
activation in the synovium, TRANCE expressed by these
same cells might function to activate dendritic cells and
indirectly stimulate T cells, mediating inflammation in the
synovium. These results imply that individual T cells in the
synovium might have different, and sometimes opposite
functional activities.
LT-a was expressed by 3–12% of the synovial CD4+
memory T cells, and the expression correlated with CCR6
expression, which is expressed by 39% of the synovial
CD4+ memory T cells. However, there were no LT-a-
expressing CD4+ T cells that also produced IFN-g,
although synovial CD4+ memory T cells that produced
each cytokine were found in abundance. It has been
reported that CCR6 is expressed by resting peripheral
memory T cells [17], whereas LT-a expression is associ-
ated with the presence of lymphocytic aggregates in syn-
ovial tissue [7]. The correlation between the expression of
these two markers therefore suggests the possibility that
CCR6 might play a role in the development of aggregates
of CD4+ T cells that are characteristically found in rheuma-
toid synovium.
TRANCE is known to be expressed by activated T cells,
and can stimulate dendritic cells and osteoclasts [18]. Of
note, TRANCE-mediated activation of osteoclasts has
recently been shown [19] to play an important role in the
damage to bone found in experimental models of inflam-
matory arthritis. Recently, the presence of TRANCE in
rheumatoid synovium was reported [24,25]. It is therefore
of interest that TRANCE was expressed by 3–16% of the
RA synovial CD4+ memory T cells. Of note, TRANCE
expression correlated with IL-10, TNF-a, and CXCR4
expressions. Especially noteworthy was that 67% of TNF-
a-positive cells expressed TRANCE. In concert, TNF-a
and TRANCE expressed by this subset of CD4+ memory
T cells might make them particularly important in mediating
the bony erosions that are characteristic of RA.
Interestingly, there was a correlation between expression
of IFN-g and IL-10 in RA peripheral blood CD4+ memory T
cells. Production of IL-10 in humans differs from that in the
mouse, in that IL-10 production does not appear to be
restricted to Th2 cells [9]. As noted here, RA peripheral
CD4+ T cells could express both IFN-g and IL-10. In RA
peripheral blood, CD154 expression correlated with
CXCR3 by CD4+ memory T cells. It has been claimed
[15] that CXCR3 was preferentially expressed by in vitro
generated Th1 cells. However, in the present study
CXCR3 did not correlate with IFN-g expression. Although
IFN-g and TNF-a mRNAs were expressed in vivo by
peripheral blood CD4+ T cells from RA patients, LT-a
mRNA was not detected, whereas IFN-g, TNF-a, and LT-a
were not detected from healthy donors. These findings
indicate that RA peripheral blood CD4+ memory T cells
are stimulated in vivo, but that they do not express LT-a
mRNA. Previous studies have documented the presence
of IFN-g and IL-10 mRNA in circulating T cells of RA
patients [26,27]. The present studies indicate that the fre-
quency of CD4+ memory T cells that express IFN-g in the
blood and synovium is comparable, although the percent-
ages that secrete IFN-g are not known. These results imply
that activated CD4+ memory T cells migrate between
blood and synovium, although the direction of the traffick-
ing is unknown. The presence of LT-a mRNA in synovium
but not in blood indicates that CD4+ memory cells are
further activated in the synovium, and that these activated
CD4+ memory T cells are retained in the synovium until
LT-a mRNA decreases.
In conclusion, CD4+ memory T cells are biased toward
Th1 cells in RA synovium and peripheral blood. In the syn-
ovium, IFN-g and LT-a were produced by individual cells,
whereas in the rheumatoid blood no LT-a-producing cells
Arthritis Research    Vol 2 No 5 Nanki and Lipskywere detected. Furthermore, there were modest correla-
tions between individual cells that expressed particular
cytokines and certain chemokine receptor mRNAs.
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